(NYSE: SOLV) Solventum's forecast annual revenue growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 10.93%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.72%.
Solventum's revenue in 2025 is N/A.On average, 3 Wall Street analysts forecast SOLV's revenue for 2025 to be $1,428,127,664,728, with the lowest SOLV revenue forecast at $1,421,593,242,030, and the highest SOLV revenue forecast at $1,439,987,404,387. On average, 3 Wall Street analysts forecast SOLV's revenue for 2026 to be $1,451,584,385,106, with the lowest SOLV revenue forecast at $1,427,639,634,480, and the highest SOLV revenue forecast at $1,484,271,873,707.
In 2027, SOLV is forecast to generate $1,461,499,432,200 in revenue, with the lowest revenue forecast at $1,446,815,336,250 and the highest revenue forecast at $1,476,183,528,150.